LYTIR

Insider · SEC Form 4 · Director

Posard Matthew L.

In the 12 months to Nov 8, 2026, on the open market: sold $2.6M of HALO. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $2.6M in total.Sep: Insider sales $2.0MOct: Insider sales $568KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $2.6M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. HALOSold: HALOZYME THERAPEUTICS, INC. Oct 1, 2026 5,230 shares filed Oct 2, 2026 4 transactions 10b5-1 plan filing $568K
  2. HALOSold: HALOZYME THERAPEUTICS, INC. Sep 16, 2026 18,996 shares filed Sep 17, 2026 4 transactions 10b5-1 plan filing $2.0M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.